Sine Reker Hadrup 

Professor, DTU Health Technology (Experimental and Translational Immunology (XTI)

Email: sirha@dtu.dk

About Sine Reker Hadrup: Sine Reker Hadrup is a Professor and Head of the Section for Experimental and Translational Immunology at the Department of Health Technology, DTU. She focuses on the role of T-cells in cancer immunotherapy, emphasizing neoantigen discovery, personalized cancer vaccines, and T-cell receptor (TCR) engineering. Her research contributes to understanding immune responses to tumors, developing predictive biomarkers for immunotherapy, and designing therapies like personalized vaccines targeting neoantigens. She has been instrumental in advancing experimental models for T-cell-based cancer treatments, including adoptive T-cell therapy and immune checkpoint inhibition. Professor Hadrup’s work aligns with UN SDGs related to health innovation and cancer treatment.

DTU Health Tech Experimental and Translational Immunology (XTI)

TU Health Tech advances health and quality of life through innovative technologies in prevention, diagnostics, and treatment. The department combines expertise from fields like physics, biology, and computer science to create sustainable healthcare solutions .

The Experimental and Translational Immunology (XTI) section focuses on understanding immune mechanisms relevant to disease and developing strategies to correct immune defects or alterations. The section emphasizes the development of advanced technologies for studying immune cells, utilizing tools like polychromatic flow cytometry, cell sorting, single-cell sequencing, genetic and transcriptomic analyses, and in vitro and in vivo immune models. Comprised of experimental immunologists, technical specialists, and bioinformaticians, xTI includes six research groups that collaborate closely to achieve its goals.